Skip to search formSkip to main contentSkip to account menu

Transcription-mediated Amplification

Known as: Transcription Mediated Amplification 
A technique used to selectively replicate nucleic acid sequences from RNA templates using reverse transcriptase and RNA polymerase. Reverse… 
National Institutes of Health

Related topics

Related topics

1 relation
Clinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Interpretation of positive transcription‐mediated amplification test results from polymerase chain reaction–negative samples obtained after treatment of chronic hepatitis C
The Siemens VERSANT® transcription‐mediated amplification (TMA) assay is extremely sensitive for the detection of hepatitis C… 
Review
2008
Review
2008
PROCLEIX® West Nile virus assay based on transcription-mediated amplification
The PROCLEIX® West Nile virus (WNV) assay is based on transcription-mediated amplification and is the most sensitive nucleic acid… 
Review
2006
Review
2006
APTIMA® transcription-mediated amplification assays for Chlamydia trachomatis and Neisseria gonorrhoeae
The APTIMA® transcription-mediated amplification assays for Chlamydia trachomatis and Neisseria gonorrhoeae have the greatest… 
2006
2006
Sensitivity of hepatitis B virus DNA transcription‐mediated amplification testing in hepatitis B surface antigen–positive blood donations
BACKGROUND: The objective was to evaluate the performance of nucleic acid testing (NAT) in the detection of hepatitis B virus… 
2005
2005
Significance of hepatitis B virus DNA clearance and early prediction of hepatocellular carcinogenesis in patients with cirrhosis undergoing interferon therapy: Long‐term follow up of a pilot study
Background and Aim:  Because the anti‐carcinogenic effect and mechanism of interferon (IFN) in patients with hepatitis B virus… 
2004
2004
Improved detection of HCV Infection in hemodialysis patients using a new HCV RNA qualitative assay: experience of a transplant center.
2003
2003
HCV viral load in anti‐HCV‐reactive donors and infectivity for their recipients
BACKGROUND:  An attempt has been made to determine the minimum level of HCV nucleic acid in donors associated with infection of… 
2003
2003
Development of real‐time detection direct test for hepatitis B virus and comparison with two commercial tests using the WHO international standard
Aims:  A highly reproducible and sensitive hepatitis B virus real‐time detection direct (HBV RTD‐direct) test using DNA… 
2003
2003
Evaluation of a transcription‐mediated amplification‐based HCV and HIV‐1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testing system
BACKGROUND : NAT was introduced for HCV RNA in 1999 to screen blood donations and improve the safety of the blood supply. 
1998
1998
New method to measure telomerase activity by transcription-mediated amplification and hybridization protection assay.
Telomerase is a ribonucleoprotein complex that uses RNA as a template for the addition of telomeric repeats. The development of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)